期刊文献+

类风湿关节炎的主要症状和治疗药物的合理应用 被引量:5

下载PDF
导出
摘要 类风湿关节炎(RA)是以对称性多关节炎为主要临床表现的异质性、系统性、自身免疫性疾病。类风湿性关节炎(RA)是一种慢性、系统性的炎性疾病,全球的发病率约为0.8%。这种病的发病年龄为30~50岁,据估计,美国每10万男性、女性中,分别有25人、54人患有类风湿性关节炎。目前我国约有近600万人患有该病,女性明显多于男性。是一种到目前为止病因还未完全阐明,由于人体免疫功能紊乱所引起的自身免疫性疾病。该病的发生与遗传因素有关,在类风关病人的家族中,类风关的发病率比健康人群家族高2-10倍。类风湿关节炎是慢性、进行性、侵袭性疾病,如未适当治疗,病情逐渐加重发展。因此早期诊断、早期治疗至关重要。本病呈全球性分布,是造成人类丧失劳动力和致残的主要原因之一。
作者 林涛
出处 《黑龙江医药》 CAS 2014年第4期910-913,共4页 Heilongjiang Medicine journal
  • 相关文献

参考文献3

二级参考文献22

  • 1Saag KG,Criswell LA,Sems KM,et al. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness. Arthritis Rheum,1996,39:1818-1825.
  • 2van Everdingen AA,Jacobs JW,Siewertsz Van Reesema DR,et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis:clinical efficacy,disease-modifying properties,and side effects:a randomized,double-blind,placebo-controlled clinical trial. Ann Intern Med,2002,136:1-12.
  • 3American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum,2002,46:328-346.
  • 4Hansen M,Podenphant J,Florescu A,et al. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis:clinical benefits and skeletal side effects. Ann Rheum Dis,1999,58:713-718.
  • 5van Everdingen AA,Siewertsz Van Reesema DR,Jacobs JW,et al. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies. Arthritis Rheum,2004,51:233-238.
  • 6Bijlsma JW,Boers M,Saag KG,et al. Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis,2003,62:1033-1037.
  • 7Boers M,Nurmohamed MT,Doelman CJ,et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis,2003,62: 842-845.
  • 8van Everdingen AA,Siewertsz Van Reesema DR,Jacobs JW,et al. Low-dose glucocorticoids in early rheumatoid arthritis:discordant effects on bone mineral density and fractures? Clin Exp Rheumatol,2003,21: 155-160.
  • 9American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum,2001,44:1496-1503.
  • 10Piper JM,Ray WA,Daugherty JR,et al. Corticosteroid use and peptic ulcer disease:role of nonsteroidal anti-inflammatory drugs. Ann Intern Med,1991,114:735-740.

共引文献5

同被引文献36

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部